antimicrobial resistance and global health security · global health security agenda vision: a...
TRANSCRIPT
Lucy Boulanger, MDDivision of Global Health Protection
Centers for Disease Control and Prevention
Antimicrobial Resistance and Global Health Security
National Center for Emerging and Zoonotic Infectious Diseases
Division of Healthcare Quality Promotion
AMR Requires Global Action
Antimicrobial Resistance
AMR Knows No Borders
A health threat anywhere is a health threat everywhere
Global Aviation Network
Source: The Lancet 380:9857, 1-7 Dec 2012, pp. 1946-55. www.sciencedirect.com/science/article/pii/S0140673612611519Note: Air traffic to most places in Africa, regions of South America, and parts of central Asia is low. If travel increases in these regions, additional introductions of vector-borne pathogens are probable
*National data means data obtained from official sources, but not that data necessarily are representative for the population or country as a whole
Available National Data* on Resistance for 9 AMR indicators
WHO: Antimicrobial Resistance. Global report on surveillance 2014
WHO Global Report on surveillance 2014
Can National Reference Labs do AST?
NRL can do AST NRL participates in EQA
WHO Global Report on Surveillance 2014
Key points
Widespread high levels of AMR
– % of resistance among tested isolates
Significant gaps
– No global system on surveillance of antibacterial resistance (ABR)
– Lack of harmonized standards, data sharing, and coordination
Source: The Review on Antimicrobial Resistance, May 2016
http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
Yearly Deaths Attributable to AMR in 2050
Tackling Antimicrobial Resistance on Many Fronts
Global priorities & objectives
Country ownership and national commitments
Technical expertise
Foundational capacities
Healthcare provider buy-in; link to infection control and prevention
Patient awareness
11
Global Action Plan on Antimicrobial Resistance
Five strategic objectives
1. Improve awareness and understanding
2. Strengthen the knowledge and evidence base through surveillance and research
Member States request WHO (2015 WHA Resolution)
“…develop and implement an integrated global program for surveillance of antimicrobial resistance across all sectors…”
3. Reduce the incidence of infection
4. Optimize the use of antimicrobial medicines
5. Develop the economic case for sustainable investment
12
GLASS Guiding Principles
1. Foster national AMR surveillance systems
• In coordination with the national strategy for AMR
• Building upon existing surveillance structures
2. Gather epidemiological, clinical and microbiological data
3. Stepwise approach to meet local and global priorities
4. GLASS Early implementation focus on bacterial pathogens
• Priority specimens and bacterial pathogens in human
• Progressive inclusion of other types of other AMR-related surveillance (e.g., food chain, antimicrobial use, environment)
GLASS – N. Delhi, Feb 2016
Global Health Security Agenda
Vision: A world safe and
secure from global health
threats posed by infectious
diseases…
– GHSA launched in
February 2014 with leaders
from 28 countries, WHO,
OIE and FAO
– By September 2014: 44
countries joined the GHSA
– June 2015, G7 committed to
assist at least 60+ countries
Global Health Security – “...the activities required, both proactive and reactive, to minimize vulnerability to acute public health events that endanger the collective health of populations living across geographical regions and international boundaries” (World Health Assembly Report, 2007)
• In 2003, SARS cost $30 billion in only 4 months• The anthrax attacks of 2001 infected 22 people,
killed 5, and cost more than $1 billion to clean up • The 2009 H1N1 influenza pandemic killed 284,000
people in its first year alone • AIDS spread silently for decades
Where50 countries have committed to the global health security agenda
Global Health Security Agenda
“…the good news is today, our nations have begun to answer the call. Together, our countries have made over 100 commitments both to strengthen our own security and to work with each other to strengthen the security of all countries’ public health systems.”
President Barack Obama, 2014GHSA Summit Greeting Ebola Survivor Dr. Melvin Korkor from Liberia
Where is the US committed in 2016?
High Risk Non-Affected Ebola CountriesBeninGambiaGuinea BissauMauritaniaNigeriaTogo
GHS Phase 1BangladeshBurkina FasoCameroonCote d’IvoireGuineaEthiopiaIndiaIndonesiaKenya
LiberiaMaliPakistanSenegalSierra LeoneTanzaniaUganda Vietnam
GHS Phase IICambodiaDemocratic Republic of CongoGeorgiaGhanaHaitiJordanKazakhstan
LaosMalaysiaMozambiquePeruRwandaThailandUkraine
Action Packages to Achieve Targets
Antimicrobial Resistance
Zoonotic Diseases
Biosafety/Biosecurity
Immunization
National Laboratory Systems
Surveillance
Reporting
Workforce Development
Emergency Operations Centers
Linking Public Health with Law Enforcement
and Multisectoral Rapid Response
Medical Countermeasures and Personnel Deployment
Action Packages to Achieve Targets
Antimicrobial
Resistance
Prevent avoidablecatastrophes
5-Year Target:
• Integrated and global package of activities to
combat AMR
Desired Impact:
• Enhance infection prevention and control
• Prevent the emergence and spread of AMR,
especially among drug-resistant bacteria
• Strengthen surveillance and laboratory
capacity
GHSA Antimicrobial Resistance Action Package
Five-Year Target:
Develop an integrated and global package of activities to combat antimicrobial resistance, including:
• Each country has its own national comprehensive plan
• Strengthen surveillance and laboratory capacity at the national and international level
• Improved conservation of existing treatments and collaboration to support the sustainable development of new antibiotics, alternative treatments, preventive measures and rapid, point-of-care diagnostics, including systems to preserve new antibiotics
GHSA Antimicrobial Resistance Action Package
As Measured by:
• Number of comprehensive plans to combat antimicrobial resistance agreed and implemented at a national level, and yearly reporting against progress towards implementation at the international level
• Number of countries actively participating in a twinning framework, with countries agreeing to assist other countries in developing and implementing comprehensive activities to combat antimicrobial resistance, including use of support provided by international bodies to improve the monitoring of antimicrobial usage and resistance in humans and animals.
GHSA Antimicrobial Resistance Action Package
Desired National Impact:
• Comprehensive action to enhance infection prevention and control activities to prevent the emergence of AMR.
• Nations will • strengthen surveillance and laboratory capacity
• ensure uninterrupted access to essential antibiotics of assured quality
• regulate and promote the rational use of antibiotics in human medicine and in animal husbandry and other fields as appropriate
• support existing initiatives to foster innovations in science and technology for the development of new antimicrobial agents
JEE Scorecard for AMR
JEEs Completed and Planned March 2017
WHO link to published country reports:http://www.who.int/ihr/procedures/implementation/en/
GHSA Country Joint External Evaluations
• Provides an independent and transparent
assessment process, joint peer-based
collaborative approach highly appreciated
• Enable country and partners to identify
gaps and development needs and build an
implementation plan for closing the gaps
• Foster true cross-sector – ‘One Health’
approach to security in Ethiopia
• All countries assessed have agreed to
publish results www.GHSagenda.org
• Ethiopia already using findings to develop
national capacities
https://stm.fi/en/international-cooperation/ghsahttps://ghsagenda.org/assessments.html
Thank You.
For more information please contact Centers for Disease Control and Prevention
1600 Clifton Road NE, Atlanta, GA 30333
Telephone: 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348
Visit: www.cdc.gov | Contact CDC at: 1-800-CDC-INFO or www.cdc.gov/info
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
National Center for Emerging and Zoonotic Infectious Diseases
Division Name in this space